Cancel
Known information
- Is a senior principal at Flagship Pioneering, where she conceives, builds, and grows the science, intellectual property, and business strategy that form the foundation of Flagship's next breakthrough startups
- Is a Business Advisory Board member of the Harvard Institute for RNA Medicine
- Is a member of the Bioscience & Investor Inclusion Group (BIIG) Diverse Talent Network Group
- Completed her Ph.D. in cell and molecular biology at the Perelman School of Medicine at the University of Pennsylvania, focusing on replication fork dynamics in the context of cancer development and therapeutics
- Has received several awards and has been granted multiple fellowships for her academic work, including an NIH NRSA Predoctoral Fellowship
- Held multiple leadership positions on Executive and Curriculum Committees during her graduate studies
- Completed a Wharton Business Foundations Specialization
- Was a mentor at the yearly Larta Institute NIH CAP FeedForward Sessions
- Her work has resulted in multiple pending patents and publications, including articles in Nature Biotechnology, Molecular Cell, and Journal of Biological Chemistry
About Alltrna
Alltrna is the world's first tRNA platform company, pioneering tRNA therapeutics to potentially treat thousands of diseases by targeting premature stop codons.
Report inaccurate information
